Some of the most recent studies have validated that breast cancer cells with aberrant expression of VCAM-1 have a growth advantage in leukocyte-rich milieu via excessive activation of the PI3K/Akt biological axis23. This evidence concerns the gene AKT1 and breast carcinoma.